CORRECTION – Upwork To Present at Upcoming Investor Conferences
SANTA CLARA, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) — In a release issued under the same headline on August 31, […]
Castor Maritime Inc. Reports Financial Results for the Three Months and Six Months Ended June 30, 2020
LIMASSOL, Cyprus, Sept. 11, 2020 (GLOBE NEWSWIRE) — Castor Maritime Inc. (NASDAQ: CTRM), (“Castor” or the “Company”), a global shipping […]
UMH PROPERTIES, INC. ANNOUNCES REDEMPTION OF ALL OUTSTANDING 8.0% SERIES B PREFERRED STOCK
FREEHOLD, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) — UMH Properties, Inc. (NYSE:UMH) (the “Company”) today announced that it will redeem […]
Artelo Biosciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 15th
LA JOLLA, Calif., Sept. 11, 2020 (GLOBE NEWSWIRE) — Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical stage biopharmaceutical company developing […]
Genetic Technologies Announces US Sales Have Commenced via Online Health Platform
MELBOURNE, Australia, Sept. 11, 2020 (GLOBE NEWSWIRE) — Molecular diagnostics company Genetic Technologies Ltd (ASX: GTG; NASDAQ: GENE, “Company”) is […]
CR Capital Corp. Announces Summer Glenrock Property Exploration Results
TORONTO, Sept. 11, 2020 (GLOBE NEWSWIRE) — CR Capital Corp. (TSX-V / CIT) (“CR Capital” or the “Company“) is pleased […]
Ascendant Digital Acquisition Corp. Announces the Separate Trading of its Ordinary Shares and Warrants, Commencing September 14, 2020
NEW YORK, Sept. 11, 2020 (GLOBE NEWSWIRE) — Ascendant Digital Acquisition Corp. (NYSE: ACND.U) (the “Company”) today announced that, commencing […]
Stitch Fix to Present at the KeyBanc Capital Markets Future of Technology Series
SAN FRANCISCO, Sept. 11, 2020 (GLOBE NEWSWIRE) — Stitch Fix, Inc. (NASDAQ: SFIX), the leading online personal styling service, today […]
Extended Stay America Announces Chief Financial Officer Transition
CHARLOTTE, N.C., Sept. 11, 2020 (GLOBE NEWSWIRE) — Extended Stay America, Inc. and its paired-share REIT, ESH Hospitality, Inc. (together, the “Company”) […]
Prasinezumab Slows Progression on Measures of Parkinson’s Disease in Phase 2 Study
First potentially disease-modifying, anti-alpha-synuclein antibody to demonstrate signals of efficacy on multiple pre-specified secondary and exploratory clinical endpoints, including measures [...]
